|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q3 FY2021
As of Sep 30, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||||||||||||
| Cash and amounts due from depository institutions | ||||||||||||||||||||
| Interest-earning deposits | ||||||||||||||||||||
| Total cash and cash equivalents | ||||||||||||||||||||
| Interest-earning time deposits | ||||||||||||||||||||
| Debt securities available for sale, at fair value | ||||||||||||||||||||
| Equity investments, at fair value | ||||||||||||||||||||
| Loans held for sale | ||||||||||||||||||||
| Loans receivable, net of allowance for credit losses of $31,914 and $32,373 respectively | ||||||||||||||||||||
| Loans receivable, net of allowance for credit losses of $40,980 and $33,691, respectively | ||||||||||||||||||||
| Federal Home Loan Bank of New York stock, at cost | ||||||||||||||||||||
| Premises and equipment, net | ||||||||||||||||||||
| Accrued interest receivable | ||||||||||||||||||||
| Other real estate owned | ||||||||||||||||||||
| Deferred income taxes, net | ||||||||||||||||||||
| Goodwill and other intangibles | ||||||||||||||||||||
| Operating lease right-of-use assets | ||||||||||||||||||||
| Bank-owned life insurance (BOLI) | ||||||||||||||||||||
| Other assets | ||||||||||||||||||||
| Total Assets | ||||||||||||||||||||
| LIABILITIES AND STOCKHOLDERS' EQUITY | ||||||||||||||||||||
| LIABILITIES | ||||||||||||||||||||
| Non-interest-bearing deposits | ||||||||||||||||||||
| Interest-bearing deposits | ||||||||||||||||||||
| Total deposits | ||||||||||||||||||||
| FHLB advances | ||||||||||||||||||||
| Subordinated debentures | ||||||||||||||||||||
| Operating lease liability | ||||||||||||||||||||
| Other liabilities | ||||||||||||||||||||
| Total Liabilities | ||||||||||||||||||||
| STOCKHOLDERS' EQUITY | ||||||||||||||||||||
| Additional paid-in capital preferred stock | ||||||||||||||||||||
| Additional paid-in capital common stock | ||||||||||||||||||||
| Retained earnings | ||||||||||||||||||||
| Accumulated other comprehensive loss | ||||||||||||||||||||
| Treasury stock, at cost, 3,233,971 shares at June 30, 2026 and December 31, 2025 | ||||||||||||||||||||
| Total Stockholders' Equity | ||||||||||||||||||||
| Total Liabilities and Stockholders' Equity |
Loading...
